TardiMed Sciences LLC 4
4 · Timber Pharmaceuticals, Inc. · Filed Sep 1, 2021
Insider Transaction Report
Form 4
TardiMed Sciences LLC
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2021-09-01$0.92/sh−150,500$138,866→ 3,733,567 total - Sale
Common Stock, par value $0.001 per share
2021-08-30$0.93/sh−100,000$92,660→ 4,034,067 total - Sale
Common Stock, par value $0.001 per share
2021-08-31$0.91/sh−150,000$136,740→ 3,884,067 total
Footnotes (3)
- [F1]The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9161 to $0.9375, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $0.91 to $0.9215, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F3]The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $0.901 to $0.9451, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.